A group of New Yorkers who are getting vaccinated against the deadly coronavirus are raising questions about the effectiveness of the city’s vaccine against the disease.
The city’s flu vaccine, known as a “pandemrix” and given to millions of people a year, is expected to have a 95% effectiveness rate, which is well below the 90% expected in the United States.
But some of the most outspoken critics of the vaccine have expressed skepticism that the city should be relying on its new product.
The public health department says that if the pandemic was really bad, the city would be forced to make drastic changes to its existing programs and to its policies in order to meet the requirements of the pandemics emergency measures.
“The pandemic in the US is very different from the pandemia of 1918,” said Dr. John Carpio, a researcher with the city Health Department.
“If we were to have had a pandemic, we would have had to do a lot more drastic things.”
Dr. Carpioni says the vaccine would have been “far worse” in 1918 than it is today.
New York City has a vaccination program that was started in the 1940s and runs through 2028.
The city’s primary health care provider, the New York City Health Department, has issued thousands of new influenza vaccinations, including a pandemrix vaccine, to more than 1 million people.
But those vaccines have a very low effectiveness rate of 95%.
The pandemixes are designed to help the city protect its people from the disease, Carpios research shows.
A number of New York residents are now receiving the pandems pandemic vaccine.
On Wednesday, the mayor of New Jersey announced that he had also been given the pandemed.
He said that the vaccine has been shown to be 100% effective.
But others are skeptical of the effectiveness and are pushing for a boycott of the flu vaccine.
“I would be very surprised if the vaccine were actually effective against this,” said the Rev. Dr. Frank Witte, a New York rabbi and former New York state health commissioner.
Witte has received more than 200,000 emails from concerned residents calling for a “complete boycott” of the new vaccine, which he said is not “necessary.”
“There is no reason for people to give up their daily dose of the vaccines,” he said.
Even some of those who have been vaccinated are skeptical.
“My first reaction to the news that the mayor is getting vaccinated was: I can’t believe this.
What are they trying to hide?” said Robert H. Schmitt, a physician at the University of Rochester Medical Center.
“This is a vaccine that has not been shown in the lab to be effective against the pandenics.
It’s not a proven vaccine.
I don’t know why they are giving this to the mayor.”
Carpio says that the reason New Yorkers are getting the pandemer vaccines is because it is a mandatory program.
The program is set up so that people have to be vaccinated every year, and the first vaccination is scheduled for June.
The mayor is expected in mid-July to give the mayor’s approval for the new pandemic vaccines.
The pandemer vaccine is a combination of two types of viruses: the common cold and the respiratory syncytial virus.
According to the city, it works by giving people who have already been vaccinated with the pandemaker vaccine the second dose of that vaccine.
Carpios findings also say that people should be told about the pandEMax, which was first released in the late 1980s.
It is a mix of the two pandemic vaccines and contains the pandemetrix vaccine.
A spokesperson for the city said the pandemo vaccines are the best protection for people in New York.
Carpionis findings are the latest in a series of research studies conducted in the past few months that have challenged the efficacy of the New Yorkers vaccine.
In January, Dr. David Esposito of Columbia University released a study that found that people who were given the new flu vaccine had an increased risk of catching the disease within 24 hours.
And in July, the CDC said that people with weakened immune systems could be more susceptible to the virus, which could increase the risk of serious complications.
Dr. Michael Witzl, an infectious diseases expert with the Johns Hopkins Bloomberg School of Public Health, says the research doesn’t necessarily show a link between weakened immune system and a higher risk of acquiring the disease from the flu.
“It’s really hard to tell if there’s a real link between the weakened immune responses and increased disease risk,” Witzli said.
“It’s possible that the weakened immunity response is a real risk factor for influenza.”
Dr. James McGlone, director of the Center for Infectious Disease Research and Policy at Johns Hopkins University, agrees that the research on weakened immune response